Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|January 13, 2018
Levels of uric acid in erectile dysfunction of different aetiologyAlessandra Barassi, Massimiliano Marco Corsi Romanelli, Raffaele Pezzilli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2017
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamidePaola Caroli, Ugo De Giorgi, Emanuela Scarpi, et al.
Frontiers in Oncology|July 12, 2021
Exploratory Analysis of 18F-3'-deoxy-3'-fluorothymidine (18F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast CancerLorenzo Fantini, Maria Luisa Belli, Irene Azzali, et al.
Minerva Medica|April 3, 2019
Alcohol-related chronic exocrine pancreatic insufficiency: diagnosis and therapeutic management. A proposal for treatment by the Italian Association for the Study of the Pancreas (AISP) and the Italian Society of Alcohology (SIA)Raffaele Pezzilli, Fabio Caputo, Gianni Testino, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 29, 2021
Pancreatic cancer in patients with autoimmune pancreatitis: A scoping reviewPeter Macinga, Lukas Bajer, Marco Del Chiaro, et al.
Clinical Nuclear Medicine|June 26, 2013
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mLMarcelo Mamede, Francesco Ceci, Paolo Castellucci, et al.
Frontiers in Oncology|January 21, 2026
Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trialMonica Celli, Roberta Gunelli, Fabio Ferroni, et al.
Seminars in Cell & Developmental Biology|September 3, 2017
Role of BAG3 in cancer progression: A therapeutic opportunityMargot De Marco, Anna Basile, Vittoria Iorio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
The American Journal of Gastroenterology|December 13, 2018
Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) RegistrySalvatore Paiella, Gabriele Capurso, Giulia Martina Cavestro, et al.
Pageof 20